KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Receivables (2016 - 2025)

Historic Receivables for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $19.5 billion.

  • Eli Lilly's Receivables rose 6144.78% to $19.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 billion, marking a year-over-year increase of 6144.78%. This contributed to the annual value of $13.3 billion for FY2024, which is 1710.63% up from last year.
  • As of Q3 2025, Eli Lilly's Receivables stood at $19.5 billion, which was up 6144.78% from $17.2 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Receivables ranged from a high of $19.5 billion in Q3 2025 and a low of $6.7 billion during Q1 2021
  • In the last 5 years, Eli Lilly's Receivables had a median value of $9.2 billion in 2023 and averaged $10.5 billion.
  • In the last 5 years, Eli Lilly's Receivables surged by 481.86% in 2021 and then skyrocketed by 6144.78% in 2025.
  • Over the past 5 years, Eli Lilly's Receivables (Quarter) stood at $8.1 billion in 2021, then rose by 5.31% to $8.6 billion in 2022, then soared by 32.45% to $11.3 billion in 2023, then rose by 17.11% to $13.3 billion in 2024, then surged by 46.57% to $19.5 billion in 2025.
  • Its Receivables was $19.5 billion in Q3 2025, compared to $17.2 billion in Q2 2025 and $14.0 billion in Q1 2025.